Ring HP
Ring HP is an FDA drug label for the active ingredient GINKGO BILOBA, CHININUM SULPHURICUM, CINCHONA OFFICINALIS, GRAPHITES, NATRUM SALICYLICUM, PLUMBUM METALLICUM, SALICYLICUM ACIDUM, SPIGELIA ANTHELMIA, THIOSINAMINUM manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230822.
Generic: GINKGO BILOBA, CHININUM SULPHURICUM, CINCHONA OFFICINALIS, GRAPHITES, NATRUM SALICYLICUM, PLUMBUM METALLICUM, SALICYLICUM ACIDUM, SPIGELIA ANTHELMIA, THIOSINAMINUM
Manufacturer: Energique, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 44911-0626
Application:
Effective: 20230822
Active Ingredients: ACTIVE INGREDIENTS: (in each drop): 11.11% of Chininum Sulphuricum 30X, Cinchona Officinalis 30X, Ginkgo Biloba 6X, Graphites 30X, Natrum Salicylicum 30X, Plumbum Metallicum 30X, Salicylicum Acidum 30X, Spigelia Anthelmia 30X, Thiosinaminum 30X.
Indications & Usage
INDICATIONS: May temporary relief noises of the ears, such as ringing, buzzing, roaring.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Contraindications
Not available.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Adverse Reactions
Not available.
More from same ingredient
No related products.